Jaguar Health (JAGX) Preferred Stock Liabilities (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Preferred Stock Liabilities of $9.5 million for Q1 2026, up 281.09% year-over-year from $2.5 million in Q1 2025, and up 281.09% quarter-over-quarter from $2.5 million in Q1 2025.
Jaguar Health (JAGX) Preferred Stock Liabilities (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Preferred Stock Liabilities for 9 consecutive years, with $9.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Stock Liabilities rose 281.09% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (up 281.09% YoY), while the FY2024 annual figure was $2.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities improved to $9.5 million in Q1 2026 per JAGX's latest filing, from $2.5 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $9.5 million in Q1 2026 and bottomed at $2.5 million in Q1 2024.
- Historically, Preferred Stock Liabilities has averaged $3.6 million across 3 years, with a median of $2.5 million in 2024.
- Annual changes were most pronounced in 2025 — Preferred Stock Liabilities changed 0.0% — and 2026, when it jumped 281.09%.
- Jaguar Health's Preferred Stock Liabilities stood at $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025, then surged by 281.09% to $9.5 million in 2026.
- Business Quant data shows JAGX's Preferred Stock Liabilities at $9.5 million in Q1 2026, $2.5 million in Q1 2025, and $2.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 9.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.47 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Sep 30, 2020 | 916,000.00 |
| Jun 30, 2020 | 10.88 Mn |
| Mar 31, 2020 | 10.38 Mn |
| Dec 31, 2019 | 9.90 Mn |
| Sep 30, 2019 | 9.00 Mn |
| Jun 30, 2019 | 9.00 Mn |
| Mar 31, 2019 | 9.00 Mn |
| Dec 31, 2018 | 9.00 Mn |
| Sep 30, 2018 | 9.00 Mn |
| Jun 30, 2018 | 9.00 Mn |
| Mar 31, 2018 | 9.00 Mn |
| Dec 31, 2017 | 6.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | 20,000.00 |